African pharmaceutical company Aspen Pharmacare is in the final stages of discussions with partners to produce mpox vaccines at its plants, according to CEO Stephen Saad, who spoke to Reuters on Tuesday. "We are in talks with various parties, and we possess the necessary capabilities to carry out this task," he stated during an interview. The United Nations Children's Fund (UNICEF), in conjunction with the Gavi vaccine alliance, Africa CDC, and the World Health Organization, had previously released a joint statement announcing an emergency tender to acquire mpox vaccines for countries facing crises. The statement indicated that, contingent on the manufacturing capacity of the producers, arrangements could be made to supply up to 12 million doses by 2025.